(Q44830791)

English

Low dose of hydrochlorothiazide, in combination with angiotensin receptor blocker, reduces blood pressure effectively without adverse effect on glucose and lipid profiles

scientific article published on 25 March 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Low dose of hydrochlorothiazide, in combination with angiotensin receptor blocker, reduces blood pressure effectively without adverse effect on glucose and lipid profiles (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

hydrochlorothiazide

1 reference

based on heuristic

inferred from title

author name string

Wakaya Fujiwara

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Hideo Izawa

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Gen Ukai

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Hiroatsu Yokoi

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Daisuke Mukaide

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Kohsuke Kinoshita

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Shin-ichiro Morimoto

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Junichi Ishii

8

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Yukio Ozaki

9

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Masanori Nomura

10

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

publication date

25 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Heart and Vessels

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

316-322

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1007%2FS00380-012-0246-5

21 January 2018

Blood pressure and cardiovascular disease in the Asia Pacific region

1 reference

https://api.crossref.org/works/10.1007%2FS00380-012-0246-5

21 January 2018

Antihypertensive efficacy of angiotensin receptor blockers in combination with hydrochlorothiazide: a review of the factorial-design studies

1 reference

https://api.crossref.org/works/10.1007%2FS00380-012-0246-5

21 January 2018

An extremely high dose of losartan affords superior renoprotection in the remnant model

1 reference

https://api.crossref.org/works/10.1007%2FS00380-012-0246-5

21 January 2018

Fixed combination of candesartan with hydrochlorothiazide in patients with severe primary hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS00380-012-0246-5

21 January 2018

Incident diabetes in clinical trials of antihypertensive drugs.

1 reference

https://api.crossref.org/works/10.1007%2FS00380-012-0246-5

21 January 2018

Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).

1 reference

https://api.crossref.org/works/10.1007%2FS00380-012-0246-5

21 January 2018

Anti-inflammatory and metabolic effects of candesartan in hypertensive patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00380-012-0246-5

21 January 2018

The role of maternal gut hormones in normal pregnancy: fasting plasma active glucagon-like peptide 1 level is a negative predictor of fetal abdomen circumference and maternal weight change

1 reference

https://api.crossref.org/works/10.1007%2FS00380-012-0246-5

21 January 2018

Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1007%2FS00380-012-0246-5

21 January 2018

Combination therapy with candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg provides the full additive antihypertensive effect of the components: A randomized, double-blind, parallel-group study in primary care

1 reference

https://api.crossref.org/works/10.1007%2FS00380-012-0246-5

21 January 2018

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

1 reference

https://api.crossref.org/works/10.1007%2FS00380-012-0246-5

21 January 2018

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

1 reference

https://api.crossref.org/works/10.1007%2FS00380-012-0246-5

21 January 2018

Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00380-012-0246-5

21 January 2018

Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS00380-012-0246-5

21 January 2018

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

1 reference

https://api.crossref.org/works/10.1007%2FS00380-012-0246-5

21 January 2018

Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00380-012-0246-5

21 January 2018

Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance

1 reference

https://api.crossref.org/works/10.1007%2FS00380-012-0246-5

21 January 2018

Fasting glucagon-like peptide-1 and its relation to insulin in obese children before and after weight loss

1 reference

https://api.crossref.org/works/10.1007%2FS00380-012-0246-5

21 January 2018

Decreased glucagon-like peptide 1 fasting levels in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS00380-012-0246-5

21 January 2018

Effects of losartan/hydrochlorothiazide treatment, after change from ARB at usual dosage, on blood pressure and various metabolic parameters including high-molecular weight adiponectin in Japanese male hypertensive subjects

1 reference

https://api.crossref.org/works/10.1007%2FS00380-012-0246-5

21 January 2018

Effects of losartan on serum total and high-molecular weight adiponectin concentrations in hypertensive patients with metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00380-012-0246-5

21 January 2018

Effects of telmisartan on insulin resistance in Japanese type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00380-012-0246-5

21 January 2018

Thiazide diuretics enhance nocturnal blood pressure fall and reduce proteinuria in immunoglobulin A nephropathy treated with angiotensin II modulators

1 reference

https://api.crossref.org/works/10.1007%2FS00380-012-0246-5

21 January 2018

Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjects

1 reference

https://api.crossref.org/works/10.1007%2FS00380-012-0246-5

21 January 2018

Antihypertensive efficacy and tolerability of candesartan-hydrochlorothiazide 32/12.5 mg and 32/25 mg in patients not optimally controlled with candesartan monotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22447467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/22447467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma levels of glucagon like peptide-1 associate with diastolic function in elderly men.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22447467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olmesartan reduces arterial stiffness and serum adipocyte fatty acid-binding protein in hypertensive patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22447467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Candesartan cilexetil/hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Triple T).

1 reference

https://pubmed.ncbi.nlm.nih.gov/22447467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uncontrolled home blood pressure in the morning is associated with nephropathy in Japanese type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22447467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of a combination tablet of candesartan cilexetil and hydrochlorothiazide in insufficiently controlled primary hypertension--comparison with a combination of losartan and hydrochlorothiazide

1 reference

https://pubmed.ncbi.nlm.nih.gov/22447467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

1 reference

https://pubmed.ncbi.nlm.nih.gov/22447467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/22447467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://pubmed.ncbi.nlm.nih.gov/22447467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00380-012-0246-5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

release_4pxlwju5wjehnl6v3fjfq4qhfa

1 reference

https://api.fatcat.wiki/v0/release/4pxlwju5wjehnl6v3fjfq4qhfa

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44830791&oldid=2206948952"